Shares of health-care companies ticked down as traders hedged their bets on the outlook for growth in the sector, given regulatory pressure. Loxo Oncology shares soared after the company released positive clinical-trial data for a cancer drug candidate. Shares of supplement maker Herbalife declined after sales lagged Wall Street targets.
Continue Reading Below
-Rob Curran, firstname.lastname@example.org
(END) Dow Jones Newswires
June 05, 2017 16:16 ET (20:16 GMT)